Janet Patricia Zayas

Dr. Janet Patricia Zayas

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 September 2021 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
RRRuchi Roy
Ruchi Roy
JZJanet Patricia Zayas
Janet Patricia Zayas
MMMohamed F. Mohamed
Mohamed F. Mohamed
AAAnahita Aboonabi
Anahita Aboonabi
KDKaylee Delgado
Kaylee Delgado
Sasha H ShafikhaniSasha H Shafikhani
Sasha H Shafikhani

17 April 2021 in medRxiv
Verified
Preprint
Open access
PDF file
EOEgon Anderson Ozer
Egon Anderson Ozer
LSLacy M. Simons
Lacy M. Simons
Adewumi OlubusuyiAdewumi Olubusuyi
Adewumi Olubusuyi
AFAdeola Fowotade
Adeola Fowotade
EOEwean C. Omoruyi
Ewean C. Omoruyi
RLRamón Lorenzo-Redondo
Ramón Lorenzo-Redondo
The emergence of new SARS-CoV-2 variants with enhanced transmissibility or decreased susceptibility to immune responses is a major threat to global efforts to end the coronavirus disease 2019 (COVID-19) pandemic. Disparities in viral genomic surveillance capabilities and efforts have resulted in gaps in our understanding of the viral population dynamics across the globe. Nigeria, despite having the largest population of any nation in Africa, has had relatively little SARS-CoV-2 sequence data made publicly available. Here we report the whole-genome sequences of 74 SARS-CoV-2 isolates collected from individuals in Oyo State, Nigeria in January 2021. Most isolates belonged to either the B.1.1.7 Alpha “variant of concern” or the B.1.525 Eta lineage, which is currently considered a “variant of interest” containing multiple spike protein mutations previously associated with enhanced transmissibility and possible immune escape. Nigeria has the highest reported frequency of the B.1.525 lineage globally with phylogenetic characteristics consistent with a recent monophyletic origin and rapid expansion. Spike protein from the B.1.525 lineage displayed both increased infectivity and decreased neutralization by convalescent sera compared to Spike proteins from other clades. These results, along with indications that the virus is outpacing the B.1.1.7 lineage in Nigeria, suggest that the B.1.525 lineage represents another “variant of concern” and further underline the importance of genomic surveillance in undersampled regions across the globe.


16 February 2022 in Viruses
Verified
Journal Article
Open access
PDF file
JZJanet Patricia Zayas
Janet Patricia Zayas
JMJoão Mamede
João Mamede
HIV mainly targets CD4+ T cells, from which Th17 cells represent a major cell type, permissive, and are capable of supporting intracellular replication at mucosal sites. Th17 cells possess well-described dual roles, while being central to maintaining gut integrity, these may induce inflammation and contribute to autoimmune disorders; however, Th17 cells’ antiviral function in HIV infection is not completely understood. Th17 cells are star players to HIV-1 pathogenesis and a potential target to prevent or decrease HIV transmission. HIV-1 can be spread among permissive cells via direct cell-to-cell and/or cell-free infection. The debate on which mode of transmission is more efficient is still ongoing without a concrete conclusion yet. Most assessments of virus transmission analyzing either cell-to-cell or cell-free modes use in vitro systems; however, the actual interactions and conditions in vivo are not fully understood. The fact that infected breast milk, semen, and vaginal secretions contain a mix of both cell-free viral particles and infected cells presents an argument for the probability of HIV taking advantage of both modes of transmission to spread. Here, we review important insights and recent findings about the role of Th17 cells during HIV pathogenesis in mucosal surfaces, and the mechanisms of HIV-1 infection spread among T cells in tissues.